Logo Image
News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtablesShorts
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Umida Nasritdinova, PharmD Candidate

Advertisement

Articles by Umida Nasritdinova, PharmD Candidate

Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis

ByUmida Nasritdinova, PharmD Candidate,Kirk E. Hevener, PharmD, PhD
December 9th 2019

A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.

Advertisement

Latest Updated Articles

  • Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis
    Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis

    December 9th 2019



Advertisement
Advertisement

Trending on Contagion Live

1

FDA Grants Priority Review for Dolutegravir in Newborns With HIV

2

10 Infectious Disease Developments That Defined Q2 2026

3

Merck, ADAP Crisis Task Force Agree to Expand IDVYNSO Access in HIV

4

Important Clinical Practice Takeaways From the DOTs and PeterPen Trials

5

HIV in 2026: Four Experts on Aging, Testing, Equity, and Prevention's Next Era

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us